Table 2.
Case # | Months of CE treatment# | Perception of improvement of symptoms (%)* | |||||||
---|---|---|---|---|---|---|---|---|---|
ADHD | BD | MD | AD | CSID | CD | SD | SZ** | ||
01f | 09 | 15 | 15 | - | 10 | 15 | 15 | 50 | - |
02m | 06 | 40 | 10 | 20 | 30 | 60 | 40 | 40 | - |
03m | 09 | 40 | 30 | 40 | 20 | 40 | 30 | 50 | - |
04m | 15 | 30 | 20 | 20 | 10 | 40 | 30 | 30 | - |
05f | 27 | 50 | 25 | 35 | 20 | 25 | 35 | 40 | - |
06m | 09 | 30 | 00 | - | 00 | 00 | 20 | - | - |
07m | 09 | 15 | 15 | 15 | 15 | 15 | 15 | 50 | - |
08f | 09 | 20 | 20 | - | 10 | 60 | 20 | 60 | - |
09m | 09 | 00 | −10 | 20 | 00 | 00 | 20 | - | - |
10m | 09 | 30 | 25 | 20 | 10 | 30 | 15 | - | - |
11m | 09 | 85 | 85 | 10 | 25 | 30 | 50 | 60 | 100 |
12m | 09 | 50 | 00 | 55 | 00 | 40 | 10 | 25 | ≥50 |
13f | 09 | 20 | 20 | 00 | 00 | 00 | 00 | 20 | ≥50 |
14m | 39 | 35 | 40 | 20 | 15 | 25 | 30 | 85 | ≥50 |
15m | 09 | 00 | 00 | 00 | 00 | 00 | 00 | 10 | 100 |
n## | 15 | 15 | 12 | 15 | 15 | 15 | 12 | 05 | |
Median | 30 | 20 | 20 | 10 | 25 | 20 | 40 | NA |
ADHD, Attention Deficit/Hyperactivity Disorder; BD, Behavioral Disorders; MD, Motor Deficits; AD, Autonomy Deficits; CSID, Communication and Social Interaction Deficits; CD, Cognitive Deficits; SD, Sleep Disorders; SZ, Seizures.
female patients.
male patients.
Lack of improvement is computed as 00% and worsening of symptoms are recorded as negative values.
Total time of CE use, including before the onset of standardized CE.
Number of patients presenting each symptom. A dash (-) indicate lack of the symptom before treatment onset. NA, Not applicable.
Scores for seizures are: 00, for lack of improvement, <50%, for reduction of <50% in the occurrence of SZ, ≥50%, for reduction of more than 50% in the occurrence of SZ; or 100% for cases of complete cessation of SZ.